This Dow Dividend Stock Could Rise 51%

years, hampering revenue. The acquisition of Wyeth will produce cost savings and growth as will the purchase of King Pharmaceuticals, a pending $3.3 billion buyout announced in October, as many of Pfizer's top drugs lose revenue to generics. Pfizer...